Recently, Beijing Beilu Pharmaceutical Co., Ltd. participated in the centralized volume-based procurement work of pharmaceuticals for the 26-province alliance in the Xinjiang Uygur Autonomous Region. ...
CPHI & PMEC China 2025 recently made a grand debut in Shanghai. This year's exhibition showcases the latest innovations and cutting-edge technologies across the entire pharmaceutical supply ch...
Recently, Beijing Beilu Pharmaceutical Co., Ltd. received the "Marketing Authorization" (MA) for its Iohexol Injection issued by Hungarian National Institute of Pharmacy and Nutrition (OGYÉ...
To facilitate a more in-depth and comprehensive understanding of the Company among a broad base of investors, the Company is scheduled to hold its 2024 Annual Online Performance Presentation on Friday...
Recently, Beilu Pharmaceutical (300016) released the "2025 First Quarter Report". Building on the stable growth in annual performance in 2024, Beilu Pharmaceutical has had a great start in 2...
Recently, Beijing Beilu Pharmaceutical Co., Ltd. received the "Marketing Authorization" (MA) issued by the Netherlands Medicines Evaluation Board (MEB) in accordance with the relevant regula...